Literature DB >> 22889122

Hepatitis B virus X protein and c-Myc cooperate in the upregulation of ribosome biogenesis and in cellular transformation.

Surendra Kumar Shukla1, Vijay Kumar.   

Abstract

Viral and cellular oncogenes are well known to enhance rRNA synthesis, leading to increased ribosome biogenesis and cell proliferation. Our study on the molecular underpinnings of the interaction between viral HBx and c-Myc, which is implicated in the development of hepatocellular carcinoma, showed a marked increase in the biosynthesis of rRNA, ribosomes and protein in hepatoma cells. A profound alteration in the nucleolar morphology and biochemical content of these cells was also observed. Increased biosynthetic activity was associated with increased cell proliferation and transformation of immortalized human hepatocytes. Furthermore, inhibition of RNA polymerase III activity impaired the proliferative advantage of hepatoma cells and transformation of immortalized hepatocytes as effectively as cisplatin treatment. These findings were corroborated in a transgenic HBx-myc microenvironment, in which an elevated hepatic level of rRNA was associated with conspicuous morphological and biochemical changes in the hepatocytic nucleoli. Thus, HBx and c-Myc seem to work cooperatively to support ribosome biogenesis and cellular transformation.
© 2012 The Authors Journal compilation © 2012 FEBS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22889122     DOI: 10.1111/j.1742-4658.2012.08745.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  15 in total

1.  The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.

Authors:  Azfar Jamal; Manickavinayaham Swarnalatha; Sarwat Sultana; Prashant Joshi; Subrat K Panda; Vijay Kumar
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  MYC regulation of cell growth through control of transcription by RNA polymerases I and III.

Authors:  Kirsteen J Campbell; Robert J White
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-01       Impact factor: 6.915

Review 3.  Ribosomal proteins: insight into molecular roles and functions in hepatocellular carcinoma.

Authors:  X Xie; P Guo; H Yu; Y Wang; G Chen
Journal:  Oncogene       Date:  2017-09-25       Impact factor: 9.867

4.  Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma.

Authors:  Pengyi Guo; Yi Wang; Chunxiu Dai; Chonglin Tao; Fang Wu; Xiaozai Xie; Haitao Yu; Qiandong Zhu; Junjian Li; Longyun Ye; Fuxiang Yu; Yunfeng Shan; Zhengping Yu; Renumathy Dhanasekaran; Rongyuan Zheng; Gang Chen
Journal:  Oncogene       Date:  2017-12-15       Impact factor: 9.867

5.  Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia.

Authors:  Surendra K Shukla; Aneesha Dasgupta; Scott E Mulder; Pankaj K Singh
Journal:  Methods Mol Biol       Date:  2019

6.  The traditional Tibetan medicine Yukyung Karne exhibits a potent anti-metastatic activity by inhibiting the epithelial to mesenchymal transition and cell migration.

Authors:  Tenzin Choedon; Ganeshan Mathan; Vijay Kumar
Journal:  BMC Complement Altern Med       Date:  2015-06-13       Impact factor: 3.659

7.  The HBx oncoprotein of hepatitis B virus potentiates cell transformation by inducing c-Myc-dependent expression of the RNA polymerase I transcription factor UBF.

Authors:  Pallavi Rajput; Surendra Kumar Shukla; Vijay Kumar
Journal:  Virol J       Date:  2015-04-14       Impact factor: 4.099

8.  MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.

Authors:  Surendra K Shukla; Venugopal Gunda; Jaime Abrego; Dhanya Haridas; Anusha Mishra; Joshua Souchek; Nina V Chaika; Fang Yu; Aaron R Sasson; Audrey J Lazenby; Surinder K Batra; Pankaj K Singh
Journal:  Oncotarget       Date:  2015-08-07

9.  Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.

Authors:  Surendra K Shukla; Aneesha Dasgupta; Kamiya Mehla; Venugopal Gunda; Enza Vernucci; Joshua Souchek; Gennifer Goode; Ryan King; Anusha Mishra; Ibha Rai; Sangeetha Nagarajan; Nina V Chaika; Fang Yu; Pankaj K Singh
Journal:  Oncotarget       Date:  2015-12-01

10.  Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.

Authors:  Oleg V Grinchuk; Surya P Yenamandra; Ramakrishnan Iyer; Malay Singh; Hwee Kuan Lee; Kiat Hon Lim; Pierce Kah-Hoe Chow; Vladamir A Kuznetsov
Journal:  Mol Oncol       Date:  2017-12-12       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.